A next-generation Biotechnology company creating off-the-shelf cellular medicines for Cancer, Infectious Diseases, and Degenerative Diseases.
Events, Presentations, and Public Engagements
B. Riley Securities’ Oncology Investor Conference
January 21st, 2021 [VIRTUAL]
Experienced Cellular Medicine
Leaders & Innovators
Backed by 100+ years of combined experience, our seasoned team of biopharmaceutical executives, scientists and clinicians have been integral to the success of numerous programs across discovery research, clinical development and commercialization in cancer immunotherapies and cell therapeutics.